• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.

    View/Open
    Published version (2.269Mb)
    Volume
    13
    Pagination
    1758 - 1771
    DOI
    10.1158/1535-7163.MCT-13-0948
    Journal
    Mol Cancer Ther
    Issue
    7
    Metadata
    Show full item record
    Abstract
    Pancreatic ductal adenocarcinoma is one of the deadliest carcinomas and is characterized by highly tumorigenic and metastatic cancer stem cells (CSC). CSCs evade available therapies, which preferentially target highly proliferative and more differentiated progenies, leaving behind CSCs as a putative source for disease relapse. Thus, to identify potentially more effective treatment regimens, we screened established and new compounds for their ability to eliminate CSCs in primary pancreatic cancer (stem) cells in vitro and corresponding patient-derived pancreatic cancer tissue xenografts in vivo. Intriguingly, we found that in vitro treatment with the antimalarial agent chloroquine significantly decreased CSCs, translating into diminished in vivo tumorigenicity and invasiveness in a large panel of pancreatic cancers. In vivo treatment in combination with gemcitabine was capable of more effectively eliminating established tumors and improved overall survival. The inhibitory effect of chloroquine was not related to inhibition of autophagy, but was due to inhibition of CXCL12/CXCR4 signaling, resulting in reduced phosphorylation of ERK and STAT3. Furthermore, chloroquine showed potent inhibition of hedgehog signaling by decreasing the production of Smoothened, translating into a significant reduction in sonic hedgehog-induced chemotaxis and downregulation of downstream targets in CSCs and the surrounding stroma. Our study demonstrates that via to date unreported effects, chloroquine is an effective adjuvant therapy to chemotherapy, offering more efficient tumor elimination and improved cure rates. Chloroquine should be further explored in the clinical setting as its success may help to more rapidly improve the poor prognosis of patients with pancreatic cancer.
    Authors
    Balic, A; Sørensen, MD; Trabulo, SM; Sainz, B; Cioffi, M; Vieira, CR; Miranda-Lorenzo, I; Hidalgo, M; Kleeff, J; Erkan, M
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/9679
    Collections
    • Centre for Haemato-Oncology [169]
    Language
    eng
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.